E K Waller
Overview
Explore the profile of E K Waller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1073
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sandesara P, Ramjee V, Ghasemzadeh N, Guo Y, Bhatia N, Li Q, et al.
J Clin Apher
. 2017 Nov;
33(3):404-408.
PMID: 29114919
Objective: Familial hypercholesterolemia (FH) is a genetic disease with very high levels of circulating low density lipoprotein cholesterol (LDL-C) levels that leads to accelerated atherosclerosis. Lipoprotein apheresis is an effective...
2.
DeFilipp Z, Rosand C, Goldstein D, Master V, Carthon B, Harris W, et al.
Bone Marrow Transplant
. 2016 Jul;
52(1):132-134.
PMID: 27427922
No abstract available.
3.
Ramanathan M, Teira P, Battiwalla M, Barrett J, Ahn K, Chen M, et al.
Bone Marrow Transplant
. 2016 Apr;
51(8):1113-20.
PMID: 27042847
Several studies have reported an association between CMV reactivation and a decreased incidence of relapse for AML after adult donor allogeneic hematopoietic cell transplantation (HCT). Limited data, however, are available...
4.
DeFilipp Z, Purcell M, Harris W, Chandra D, Gleason C, Wrammert J, et al.
Bone Marrow Transplant
. 2015 Dec;
51(4):607-9.
PMID: 26642338
No abstract available.
5.
Auletta J, Devine S, Waller E
Bone Marrow Transplant
. 2015 Dec;
51(3):333-43.
PMID: 26642333
Plasmacytoid dendritic cells (pDCs) bridge innate and adaptive immune responses and have important roles in hematopoietic engraftment, GvHD and graft-versus-leukemia responses following allogeneic hematopoietic cell transplantation (HCT). In addition, pDCs...
6.
Nickel R, Waller E, Qayed M, Chiang K
Bone Marrow Transplant
. 2015 Oct;
51(1):148-9.
PMID: 26437061
No abstract available.
7.
Gul Z, Van Meter E, Abidi M, Ditah I, Abdul-Hussein M, Deol A, et al.
Bone Marrow Transplant
. 2015 Jan;
50(3):432-7.
PMID: 25599169
Multiple reports have shown that low absolute lymphocyte count at day 30 (ALC30) after allogeneic hematopoietic SCT (AHSCT) is associated with higher risk of disease relapse and worse OS. However,...
8.
Zhang J, Mosunjac M, Moon A, Nooka A, Waller E
Bone Marrow Transplant
. 2015 Jan;
50(3):465-8.
PMID: 25581407
No abstract available.
9.
Fleischhauer K, Fernandez-Vina M, Wang T, Haagenson M, Battiwalla M, Baxter-Lowe L, et al.
Bone Marrow Transplant
. 2014 Jun;
49(9):1176-83.
PMID: 24955785
HLA-DP antigens are beta-alpha heterodimers encoded by polymorphic HLA-DPB1 and -DPA1 alleles, respectively, in strong linkage disequilibrium (LD) with each other. Non-permissive unrelated donor (UD)-recipient HLA-DPB1 mismatches across three different...
10.
Langston A, Prichard J, Muppidi S, Nooka A, Lechowicz M, Lonial S, et al.
Bone Marrow Transplant
. 2013 Oct;
49(2):185-9.
PMID: 24162613
Reduced-intensity conditioning (RIC) permits allogeneic hematopoietic progenitor cell transplantation in patients who would not be considered candidates for transplantation using a myeloablative preparative regimen because of age, comorbidities or prior...